Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 32Pain, Postoperative 18Neoplasms 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Lung Neoplasms 12Brain Neoplasms 12Prostatic Neoplasms 9Ovarian Neoplasms 8Colonic Neoplasms 8Carcinoma, Hepatocellular 8Stomach Neoplasms 7Depression 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Pain 6Head and Neck Neoplasms 6Thyroid Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leiomyoma 5Agnosia 5Neoplasm Metastasis 4Lymphoma 4Fatigue 4Delirium 4Anxiety Disorders 4Urinary Bladder Neoplasms 3Thromboembolism 3Supratentorial Neoplasms 3Stomatitis 3

Interventions

Dexamethasone 51Aprepitant 39Palonosetron 37Ondansetron 31Granisetron 22Calcium Dobesilate 14fosaprepitant 13Olanzapine 12Therapeutics 8dexamethasone acetate 7ramosetron 6casopitant 6Tropisetron 6Cyclophosphamide 6netupitant, palosentron drug combination 5dexamethasone 21-phosphate 5Radiotherapy 5Metoclopramide 5Doxorubicin 5netupitant 4dolasetron 4Dronabinol 4Acupressure 4Yoga 3Vincristine 3Tablets 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Vomiting × Saline Solution × Clear all
NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡